Research Focus

Former Employee. Human Oncology and Pathogenesis Program; Graduate Research Assistant

Recent additions – View all

1. Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression

   Journal Article

   Curran, K. J.; Seinstra, B. A.; Nikhamin, Y.; Yeh, R.; Usachenko, Y.; van Leeuwen, D. G.; Purdon, T.; Pegram, H. J.; Brentjens, R. J.
   Molecular Therapy (2015)

   Fulltext@MSK | Save
2. Constitutive expression of CD40L by CAR-modified tumor targeted T cells enhances anti-tumor efficacy both in vitro and in vivo

   Meeting Abstract

   Curran, K. J.; Seinstra, B.; Nikhamin, Y.; Yeh, R.; Usachenko, Y.; Brentjens, R. J.
   Blood (2012)

   Fulltext@MSK | Save
3. Enhanced anti-tumor efficacy of genetically modified T cells through the up-regulated expression of CD154 (CD40L)

   Meeting Abstract

   Seinstra, B.; Nikhamin, Y.; Brentjens, R.
   Human Gene Therapy (2007)

   Fulltext@MSK | Save